Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

v3.10.0.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Revenues $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development 1,332 1,061 6,801 2,260
General and administrative 1,248 1,338 3,859 2,987
Depreciation and amortization 11 5 27 13
Total operating expenses 2,591 2,404 10,687 5,260
Loss from operations (2,591) (2,404) (10,687) (5,260)
Other income (expense):        
Gain (loss) from change in fair value of warrant liability 573 (470) 1,614 (2,753)
Gain from settlement of liability 0 0 0 149
Gain from expiration of warrants 0 0 0 1,238
Other (expense) income (21) 9 (23) 8
Interest income (expense), net 1 (1) 5 (2)
Net loss $ (2,038) $ (2,866) $ (9,091) $ (6,620)
Net loss per common share – basic and diluted (in dollars per share) $ (0.08) $ (0.14) $ (0.36) $ (0.37)
Weighted-average common shares outstanding – basic and diluted 26,861,497 20,534,720 25,373,634 17,683,441
Other comprehensive income (loss):        
Foreign currency translation $ 15 $ 0 $ 21 $ 0
Comprehensive loss $ (2,023) $ (2,866) $ (9,070) $ (6,620)